NUTRIによる流動食事業の譲受
First written in FY2020-Q1. 1 of 6 entries say "Achieved", first in FY2020-Q1. Latest entry: FY2024-Q3.
No other company in this theme has enough history to compare yet.
- FY2024-Q3RestatedAnnual report
「In the previous consolidated fiscal year, higher profit from sales of nutritional foods and related products acquired from テルモ also contributed to business performance.」
Sales of nutritional foods and related products acquired from テルモ continue to be a factor behind higher profit in the Life Energy Business. - FY2024-Q1AdvancedAnnual report
「Increased orders in the Bio Business and higher profit from sales of nutritional foods and related products acquired from テルモ in the previous consolidated fiscal year also contributed to business performance.」
Sales of nutritional foods and related products acquired from テルモ in the previous consolidated fiscal year contributed to higher profit in the Life Energy Business. - FY2023-Q2Lower revenue but profit recovery due to delays in production adjustments associated with the renewal of enteral nutrition productsAnnual report
「Domestic sales of sugarcane extract for environmental deodorizing applications remained strong, and feed applications also remained steady. However, partly due to delays in production adjustments associated with the renewal of enteral nutrition products, overall revenue declined year on year, while profit recovered in part.」
While delays in production adjustments associated with the renewal of enteral nutrition products were a factor behind lower revenue, a partial recovery was indicated in the profit performance of the Life Energy Business. - FY2021-Q2ニュートリー, including the enteral nutrition business, increased profit while suspending sales activities.Annual report
「ニュートリー㈱ posted lower revenue because the impact of COVID-19 forced it to curb sales activities, but profit increased partly due to improved selling, general and administrative expenses.」
Although ニュートリー, including the enteral nutrition business, reported lower revenue due to the suspension of sales activities amid the infectious disease outbreak, profit increased as a result of improvements in selling, general and administrative expenses. - FY2020-Q3Higher revenue and higher profit due to increased sales of the enteral nutrition business and other operationsAnnual report
「ニュートリー㈱ posted higher revenue and higher profit due to increased sales of the enteral nutrition business and other operations acquired at the beginning of the fiscal year.」
Following the acquisition of the enteral nutrition business, ニュートリー increased both revenue and profit as a result of higher sales. - FY2020-Q1AchievedAnnual report
「ニュートリー㈱ posted higher revenue from the enteral nutrition business acquired at the beginning of the fiscal year, but profit declined due to higher miscellaneous expenses.」
This is the first disclosure that ニュートリー acquired the enteral nutrition business at the beginning of the current fiscal year; the acquisition itself has been completed.